Analyst stock forecast
Ultragenyx Pharmaceutical Forecast: $55.05 Analyst Target
RARE has a $55.05 target, Strong Buy rating and 19 analysts. As of 2026-08-26.
Direct answer
Ultragenyx Pharmaceutical's average price target is $55.05.
The target implies +108.1% from the recorded current price, and the consensus rating is Strong Buy.
The low target implies +5.8%, the high target implies +289.3%, and the range spans 283.4% of the current price.
Forecast evidence checked August 26, 2026.
Get free Ultragenyx Pharmaceutical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $26.46
- Average price target
- $55.05
- High price target
- $103.00
- Low price target
- $28.00
- Low target gap
- +5.8%
- Target upside
- +108.1%
- High target gap
- +289.3%
- Target range width
- 283.4%
- Consensus rating
- Strong Buy
- Analysts
- 19
- Evidence date
- August 26, 2026
- Valid through
- September 2, 2026
Explore related company data
Read the frequently asked questions.
What is Ultragenyx Pharmaceutical's average price target?
Ultragenyx Pharmaceutical's verified average price target is $55.05. The target range is $28.00 to $103.00.
How far are Ultragenyx Pharmaceutical's low and high targets from the recorded price?
The low target implies +5.8%, while the high target implies +289.3%.
How many analysts are included in Ultragenyx Pharmaceutical's consensus?
The verified consensus includes 19 analysts.
How is Ultragenyx Pharmaceutical's target upside or downside calculated?
The average target of $55.05 is divided by the recorded price of $26.46, then one is subtracted to produce +108.1%. This does not guarantee a future return.
When was Ultragenyx Pharmaceutical's analyst forecast verified?
The data was verified on 2026-08-26. The dataset is valid through 2026-09-02.